Antiplatelet Drugs
Author:
- 1 July 1995
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 50 (1) , 7-28
Abstract
Antiplatelet therapy has become a useful means of preventing acute thromboembolic artery occlusions in cardiovascular diseases. The rationale for this is an enhanced activity of circulating platelets...Keywords
This publication has 99 references indexed in Scilit:
- DefibrotideDrugs, 1993
- TiclopidineDrugs, 1990
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human plateletsBiochemical and Biophysical Research Communications, 1988
- The stimulation of arachidonic acid metabolism in human platelets by hydrodynamic stressesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.Circulation, 1985
- Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis.Circulation, 1985
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984
- Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic PatientsNew England Journal of Medicine, 1983
- Platelet aggregation in partially obstructed vessels and its elimination with aspirin.Circulation, 1976